HERSTELLUNGSVERFAHREN
European patent · EP3216802 · In force
Register entry
- Publication number
- EP3216802
- Application number
- EP17159323
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Aug 19, 2008
- Published
- Sep 13, 2017
- Granted
- Oct 7, 2020
- Protection ends at the latest
- Aug 18, 2028
- Next annual fee due
- Aug 31, 2027
- IPC classes
- C07K 16/18 (2006.01)C12N 15/67 (2006.01)C07K 16/00 (2006.01)C12P 21/02 (2006.01)C12N 7/02 (2006.01)C12N 15/85 (2006.01)
- Priority
- US 956772 P 20.08.2007
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.08.2026 → 31.08.2027
Published in Swissreg on 01.09.2026
- Dec 23, 2025
Holder’s address changed
- Owner
- Glaxo Group Limited, 980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom → Glaxo Group Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom
Published in Swissreg on 23.12.2025
- Sep 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.08.2025 → 31.08.2026
Published in Swissreg on 01.09.2025
- Sep 1, 2024
Next annual fee due on
- Next annual fee due on
- 31.08.2024 → 31.08.2025
Published in Swissreg on 01.09.2024
- Sep 1, 2023
Change
Published in Swissreg on 01.09.2023
- Sep 1, 2022
Change
Published in Swissreg on 01.09.2022
- Dec 22, 2020
Agent entered
- Representative
- Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich
Published in Swissreg on 22.12.2020
- Oct 7, 2020
Granted
Published in Swissreg on 07.10.2020
Parties
Inventor
Stevenage, Hertfordshire SG1 2NY, GB
Stevenage, Hertfordshire SG1 2NY, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.